Position in XERS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$71,105
+$24,021 QoQ
Shares Held
8,978
+10.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#184
of 238 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Truvestments Capital LLC holds $377,223 across 18 Drug Manufacturers - Specialty & Generic names. XERS ranks #2 (18.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
2,064 | $148,319 | |
| 2 | XERS |
Xeris Biopharma Holdings, Inc.
This page
|
8,978 | $71,105 | |
| 3 | ETON |
Eton Pharmaceuticals, Inc.
|
1,183 | $42,824 | |
| 4 | ORGO |
Organogenesis Holdings Inc.
|
12,152 | $29,529 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
267 | $22,102 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
284 | $18,161 | |
| 7 | VTRS |
Viatris Inc
|
600 | $9,528 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
161 | $6,605 |
All Filings in XERS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $71,105 | 8,978 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $47,084 | 8,118 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $63,726 | 8,118 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $33,691 | 4,139 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $16,685 | 3,573 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $2,871 | 847 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||